Saturday, April 2, 2022

Gilead's Kite flies higher as Yescarta leads CAR-T therapy class to earlier lymphoma treatment

Yescarta (axicabtagene ciloleucel)Gilead SciencesCell & Gene TherapyCAR-T. Share. multicolored kite against the blue sky The FDA approval puts ...
https://www.google.com/url?rct=j&sa=t&url=https://www.fiercepharma.com/marketing/gileads-kite-flies-higher-yescarta-leads-car-t-therapy-class-earlier-lymphoma-treatment&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNFxwM2i-8jVm0NYVEGG33apwKi_JA

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...